Valiant isn’t the only one hiring, others are hiring too! Check it out! (Isn’t it tempting?)
New Jersey economic development officials are giving Valeant Pharmaceuticals International Inc. $39.5 million to put its U.S. headquarters in the Garden State. Valeant completed an $8.7 billion acquisition of Bausch & Lomb in August. The pharmaceuticals firm said it would make the Rochester-based Bausch & Lomb the core of its eye-health business. But even before the deal closed, the Quebec company’s CEO, Michael Pearson, announced plans to make New Jersey Valeant’s U.S. eye-health base.
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
